• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Supraglottitis as the sole manifestation of COVID-19 in a patient who received two doses of mRNA vaccine.

作者信息

Chang Kai-Ming, Epstein Marcia E, Kennedy William A, Niknam Negin

机构信息

Division of Infectious Diseases, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, Manhasset, NY, USA.

Division of Infectious Diseases, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, Manhasset, NY, USA.

出版信息

J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1126-1128. doi: 10.1016/j.jmii.2022.04.010. Epub 2022 Apr 28.

DOI:10.1016/j.jmii.2022.04.010
PMID:35545499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9046100/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f56/9046100/568a278cf938/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f56/9046100/568a278cf938/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f56/9046100/568a278cf938/gr1_lrg.jpg

相似文献

1
Supraglottitis as the sole manifestation of COVID-19 in a patient who received two doses of mRNA vaccine.在一名接种了两剂mRNA疫苗的患者中，会厌炎作为新冠病毒病的唯一表现。
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1126-1128. doi: 10.1016/j.jmii.2022.04.010. Epub 2022 Apr 28.
2
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险：按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
3
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应（UNCoVER）：一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
4
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.在 SARS-CoV-2 初免和既往感染人群中，BNT162b2 mRNA 疫苗对细胞和体液免疫应答的动力学和持久性：加强针和突破性感染的影响。
Front Immunol. 2022 May 31;13:863554. doi: 10.3389/fimmu.2022.863554. eCollection 2022.
5
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.在接受多次 COVID-19 mRNA 疫苗接种后，一位患有 B 细胞淋巴瘤的患者体内针对 SARS-CoV-2 及其奥密克戎变异株的 T 细胞反应。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004953.
6
Improved immunologic response to COVID-19 vaccine with prolonged dosing interval in haemodialysis patients.血液透析患者延长接种间隔可提高对 COVID-19 疫苗的免疫应答。
Scand J Immunol. 2022 May;95(5):e13152. doi: 10.1111/sji.13152. Epub 2022 Mar 7.
7
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.川崎病病史患者对 COVID-19 感染和信使 RNA 疫苗接种的耐受性。
JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236.
8
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].不同 COVID-19 疫苗组合在健康个体中的安全性和免疫原性评估：一项随机、设盲、对照的 3 期临床试验 [PRIBIVAC] 的研究方案。
Trials. 2022 Jun 16;23(1):498. doi: 10.1186/s13063-022-06345-2.
9
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性：一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
10
[The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].科兴新冠疫苗第二针可能导致曾感染新冠病毒者抗体水平下降
Mikrobiyol Bul. 2022 Jan;56(1):139-142. doi: 10.5578/mb.20229913.

引用本文的文献

1
Acute epiglottitis caused by COVID-19: A systematic review.由 COVID-19 引起的急性会厌炎：系统评价。
Biomol Biomed. 2023 Jul 3;23(4):568-574. doi: 10.17305/bb.2022.8861.

本文引用的文献

1
Patient With Prior COVID-19 Infection Presenting With Acute Upper Airway Obstruction: A Case Report.既往感染过新型冠状病毒肺炎现出现急性上气道梗阻的患者：一例报告
Cureus. 2022 Mar 16;14(3):e23214. doi: 10.7759/cureus.23214. eCollection 2022 Mar.
2
COVID-19 presenting as acute epiglottitis: A case report and literature review.COVID-19 表现为急性会厌炎：病例报告及文献复习。
Auris Nasus Larynx. 2023 Feb;50(1):165-168. doi: 10.1016/j.anl.2021.12.007. Epub 2021 Dec 18.
3
Acute epiglottitis is a rare clinical presentation of coronavirus disease 2019: a case report.
急性会厌炎是 2019 冠状病毒病的一种罕见临床表现：病例报告。
Infect Dis (Lond). 2022 Apr;54(4):308-310. doi: 10.1080/23744235.2021.2014560. Epub 2021 Dec 8.
4
Acute epiglottitis in a COVID-19 positive patient.COVID-19 阳性患者的急性会厌炎。
Am J Emerg Med. 2022 Jan;51:427.e1-427.e2. doi: 10.1016/j.ajem.2021.06.077. Epub 2021 Jul 7.
5
Acute epiglottitis after COVID-19 infection.新型冠状病毒感染后的急性会厌炎
Clin Case Rep. 2021 Jul 10;9(7):e04419. doi: 10.1002/ccr3.4419. eCollection 2021 Jul.
6
Acute Epiglottitis Due to COVID-19 Infection.新型冠状病毒感染所致急性会厌炎
Eur J Case Rep Intern Med. 2021 Mar 3;8(3):002280. doi: 10.12890/2021_002280. eCollection 2021.
7
Case report: Epiglottitis in the setting of COVID-19.病例报告：新型冠状病毒肺炎背景下的会厌炎
IDCases. 2021;24:e01116. doi: 10.1016/j.idcr.2021.e01116. Epub 2021 Apr 7.
8
Pediatric COVID-19 presenting as supraglottitis with vocal cord hypomobility.表现为会厌炎伴声带活动度降低的儿童新冠肺炎
SAGE Open Med Case Rep. 2021 Feb 12;9:2050313X21989465. doi: 10.1177/2050313X21989465. eCollection 2021.
9
COVID-19 infection presenting with acute epiglottitis.表现为急性会厌炎的新型冠状病毒肺炎感染
J Surg Case Rep. 2020 Sep 8;2020(9):rjaa280. doi: 10.1093/jscr/rjaa280. eCollection 2020 Sep.